Passage Bio, Inc. Share Price
PASGPassage Bio, Inc. Stock Performance
Open $6.78 | Prev. Close $6.78 | Circuit Range N/A |
Day Range $6.78 - $6.78 | Year Range $0.26 - $8.72 | Volume 100 |
Average Traded $6.78 |
Passage Bio, Inc. Share Price Chart
About Passage Bio, Inc.
Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; and PBKR03, a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other program for huntington's disease. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. The company was incorporated in 2017 and is based in Philadelphia, Pennsylvania.
Passage Bio, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
05-Nov-25 | $6.78 | $6.78 | -1.38% |
04-Nov-25 | $6.88 | $6.88 | -6.08% |
03-Nov-25 | $7.72 | $7.32 | -3.37% |
31-Oct-25 | $7.58 | $7.58 | +6.84% |
27-Oct-25 | $7.09 | $7.09 | -2.07% |
24-Oct-25 | $7.50 | $7.24 | -4.86% |
23-Oct-25 | $8.04 | $7.61 | -6.27% |
FAQs on Passage Bio, Inc. Share Price
Can I buy Passage Bio, Inc. shares in India?
What is the share price of Passage Bio, Inc.?
What is the 5 year returns of Passage Bio, Inc.?
What are the high & low stock price of Passage Bio, Inc. today?
What is the 52-week high and low of Passage Bio, Inc. stock?